IN THIS ISSUE

Jan Greene

Lili Brillstein

Paying for care by the episodes may be the shortest path to value-based care. But administration is tricky, and early results raise questions about the savings achieved.

Timothy Kelley

Ruth Benton

Of all the “value-based” provider payment methodologies, this one’s the classic. And it may be mounting a comeback.

Peter Wehrwein

Without shared risk, shared savings might not be strong enough medicine for what ails American health care.

Joseph Burns

Ruling in same-sex marriage case extends insurance coverage, but problems with discrimination and lack of access persist.

Legislation & Regulation
Richard Mark Kirkner

David Balto, formerly FTC

One of the purposes of health care reform was to create more competition, and the recent spate of acquisitions works against that.

Medication Management
Thomas Reinke

Elliott Antman, MD

This knowledge won’t come cheap, as the system braces for new agents that could add another $42 billion to the nation’s drug bill.

Medical Device Monitor
Katherine T. Adams
Tomorrow's Medicine
Thomas Morrow, MD

The combination of a neprilysin inhibitor and an ARB rescued neprilysin inhibition from obscurity.

News & Commentary